Text Version
Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM
Gateway
TOXNET
Consumer
Health
Clinical Alerts
ClinicalTrials.gov
PubMed
Central
Privacy Policy
|
|
-
Sertraline-induced hyperglycemia:
case report.
Sansone RA, Sansone
LA.
Wright State University, Dayton, Ohio, USA.
Randy.sansone@kmcnetwork.org
Empirical studies with humans
suggest that selective serotonin reuptake inhibitors (SSRIs) may,
through increases in serotonergic activity, increase insulin secretion,
increase insulin sensitivity, and lower serum glucose levels. Indeed,
the potentially beneficial effects of SSRI treatment in diabetics are
documented. However, we describe the case of a female, with
diet-controlled, type 2 diabetes, whose glucose levels increased with
exposure to sertraline.
Publication Types:
PMID: 12906348 [PubMed - indexed for
MEDLINE]
|